US Broker Ratings

Teva Pharmaceutical Industries (TEVA) Stock Analysis: Unlocking 12.71% Potential Upside

Teva Pharmaceutical Industries (NYSE: TEVA), a pivotal player in the healthcare sector, particularly within the specialty and generic drug manufacturing industry, has captured investor attention with..

UnitedHealth Group (UNH) Stock Analysis: Navigating the Healthcare Giant’s Growth and Dividend Potential

UnitedHealth Group Incorporated (NYSE: UNH), a leading player in the healthcare plans industry, continues to hold a firm grip on the market with a substantial market..

Medtronic plc (MDT) Stock Analysis: A 41.83% Potential Upside with Strong Buy Ratings

Medtronic plc (NYSE: MDT), a global leader in the medical devices industry, is attracting significant investor interest with an impressive potential upside of 41.83%. Headquartered in..

Insulet Corporation (PODD) Stock Analysis: A 62% Potential Upside Beckons Investors

Insulet Corporation (NASDAQ: PODD) stands out in the healthcare sector, particularly in the medical devices industry, with its innovative insulin delivery systems. The company’s flagship products,..

Vertex Pharmaceuticals (VRTX) Stock Analysis: A Biotech Giant with 27.84% Potential Upside

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) stands as a formidable player in the biotechnology sector, renowned for its focus on transformative medicines targeting serious diseases. With a..

IDEXX Laboratories (IDXX) Stock Analysis: Unveiling a 26.61% Potential Upside for Investors

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a prominent player in the healthcare sector, specifically within the diagnostics and research industry, presents a compelling case for investors with..

Novartis AG (NVS) Stock Analysis: Evaluating a Potential 5.37% Upside in a Healthcare Giant

Novartis AG (NVS), a titan in the global healthcare sector, stands as a formidable presence in the pharmaceutical industry with a market capitalization of $278.64 billion...

Eli Lilly and Company (LLY) Stock Analysis: A Strong Buy with 27% Upside Potential

Investors are keeping a close eye on Eli Lilly and Company (NYSE: LLY), a titan in the healthcare sector with a market capitalization of $845.77 billion...

Thermo Fisher Scientific Inc (TMO): An Investor Outlook with Strong Buy Ratings and Robust Revenue Growth

Thermo Fisher Scientific Inc (NYSE: TMO), a dominant player in the healthcare sector, continues to captivate investors with its robust performance in the diagnostics and research..

Abivax SA (ABVX) Stock Analysis: Unpacking the 24.51% Potential Upside Amidst Strong Buy Ratings

Abivax SA (ABVX), a trailblazer in the biotechnology sector, has captured investor attention with its promising potential upside of 24.51%. Headquartered in Paris, France, this clinical-stage..

Maze Therapeutics, Inc. (MAZE) Stock Analysis: Exploring a Potential 149.49% Upside in Biotech

Maze Therapeutics, Inc. (MAZE), a clinical-stage biopharmaceutical company headquartered in South San Francisco, has garnered significant attention in the biotechnology sector for its innovative approach to..

Fortrea Holdings Inc. (FTRE) Stock Analysis: Exploring Growth Potential Amidst a $1.47 Billion Market Cap

Fortrea Holdings Inc. (NASDAQ: FTRE), a relatively new player in the biotechnology sector, is garnering attention from investors with its promising growth potential and strategic focus...

Myriad Genetics, Inc. (MYGN) Stock Analysis: Evaluating a Promising 77.94% Upside Potential

Myriad Genetics, Inc. (NASDAQ: MYGN) is a notable player in the healthcare sector, specifically in the diagnostics and research industry. Headquartered in Salt Lake City, Utah,..

Prothena Corporation plc (PRTA) Stock Analysis: Biotechnology Innovator with a 99.62% Potential Upside

Prothena Corporation plc (NASDAQ: PRTA) has emerged as a significant player within the biotechnology sector, captivating investor attention with its promising pipeline and a substantial potential..

Zevra Therapeutics, Inc. (ZVRA) Stock Analysis: Investors Eye 107% Upside Potential

Zevra Therapeutics, Inc. (NASDAQ: ZVRA) presents a compelling opportunity for investors interested in the biotechnology sector, particularly those focused on companies addressing rare diseases. With a..

Standard BioTools Inc. (LAB) Stock Analysis: A 55% Potential Upside Beckons Investors

Standard BioTools Inc. (NASDAQ: LAB), a player in the medical devices sector, offers a compelling opportunity for investors with an eye for high-potential biotech stocks. Headquartered..

Arbutus Biopharma Corporation (ABUS) Stock Analysis: Exploring a 20% Potential Upside in the Biotech Sector

Arbutus Biopharma Corporation (NASDAQ: ABUS) is gaining attention in the biotechnology sector, driven by its promising pipeline focused on novel therapeutics for infectious diseases, particularly chronic..

OrthoPediatrics Corp. (KIDS) Stock Analysis: Navigating a 40% Potential Upside with Strategic Growth

OrthoPediatrics Corp. (NASDAQ: KIDS), a prominent player in the healthcare sector focusing on medical devices, presents a compelling opportunity for investors seeking growth in the pediatric..

Kamada Ltd. (KMDA) Stock Analysis: Unveiling a 57% Potential Upside in the Healthcare Sector

For investors seeking opportunities in the healthcare sector, Kamada Ltd. (NASDAQ: KMDA) presents a compelling case with its significant potential upside of 57.38%. This Israeli-based company,..

MeiraGTx Holdings plc (MGTX) Stock Analysis: Unpacking a Promising 188% Upside in Biotech Innovation

Investors with a keen eye on the biotechnology sector should take a closer look at MeiraGTx Holdings plc (NASDAQ: MGTX). Known for its cutting-edge work in..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds